Clinical Trial Update: Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity and safety of a rabies vaccine administered under two simulated post-exposure schedules. The trial results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Rabies | Phase 4 | Status: COMPLETED | Results posted: 2014-05-05